果糖胺测定：糖尿病疾病中期代谢控制参数的一项指标。
Fructosamine assay: an index of medium-term metabolic control parameters in diabetic disease.
作者信息
Lapolla A, Poli T, Barison A, Fedele D
机构信息
Institute of Internal Medicine, Medical Pathology I, Padua, Italy.
出版信息
Diabetes Res Clin Pract. 1988 Feb 19;4(3):231-5. doi: 10.1016/s0168-8227(88)80023-8.
The fructosamine levels and some metabolic control parameters were evaluated in 120 diabetics and in 60 controls. Higher levels of fructosamine were found in diabetics compared to normals (3.22 +/- 0.06 vs. 1.82 +/- 0.05 mmol/l; P less than 0.001). Positive correlations were found between fructosamine and metabolic control parameters in diabetic subjects. Moreover, non-insulin-dependent diabetic subjects had better correlations. The study of fructosamine variation in relation to plasma glucose change showed that fructosamine levels were modified after at least 2 weeks of good metabolic control. In conclusion, the fructosamine assay could be a useful method for medium-term metabolic control evaluation.
对120名糖尿病患者和60名对照者的果糖胺水平及一些代谢控制参数进行了评估。与正常人相比，糖尿病患者的果糖胺水平更高（3.22±0.06 vs. 1.82±0.05 mmol/l；P<0.001）。在糖尿病患者中，果糖胺与代谢控制参数之间存在正相关。此外，非胰岛素依赖型糖尿病患者的相关性更好。果糖胺变化与血浆葡萄糖变化关系的研究表明，至少在良好代谢控制2周后，果糖胺水平会发生改变。总之，果糖胺检测可能是一种用于中期代谢控制评估的有用方法。
Zotero 插件